Test Anxiety on Bowel Health and Constipation in Students
The Effect of Test Anxiety on Bowel Health and Constipation in University Students
This observational cross-sectional study aims to examine the relationship between test anxiety, bowel health, and constipation in university students. The study will include undergraduate students aged 18 years and older who are studying in the Physiotherapy and Rehabilitation Department at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires during a single face-to-face assessment session. Constipation status will be evaluated using the Rome IV criteria, stool form will be assessed using the Bristol Stool Scale, constipation severity will be assessed using the Constipation Severity Instrument, and test anxiety level will be assessed using the Test Anxiety Inventory. Sociodemographic characteristics and bowel-related symptoms will also be recorded.
The study does not include any intervention or treatment. The findings are expected to help better understand whether test anxiety during examination periods is associated with bowel health problems and constipation in university students.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Constipation is a common gastrointestinal problem that may affect quality of life, daily activities, and psychosocial well-being. University students may be particularly vulnerable to bowel habit changes during examination periods because of increased academic stress and test-related anxiety.
This study is designed as an observational, cross-sectional, and analytical study. It will evaluate whether test anxiety is associated with bowel health indicators and constipation among university students during the final examination period. The study will be conducted at Lokman Hekim University with undergraduate students from the Department of Physiotherapy and Rehabilitation.
After providing informed consent, participants will complete self-report forms and questionnaires in a single face-to-face assessment session. The assessment will include questions about sociodemographic characteristics, bowel habits, bowel-related symptoms, constipation status, stool form, constipation severity, and test anxiety level. No intervention, treatment, randomization, or follow-up assessment will be performed.
The study is expected to provide information about the possible relationship between psychological stress related to examinations and bowel health in university students. The findings may contribute to a better understanding of stress-related bowel problems and may support future preventive approaches for young adults.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Demet Öztürk, Phd
- Numéro de téléphone: +905068394288
- E-mail: demett.ozturkk@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Mustafa Sarı, Phd
- Numéro de téléphone: +905068394288
- E-mail: mustafa.sari@lokmanhekim.edu.tr
Lieux d'étude
-
-
Ankara
-
Ankara, Ankara, Turquie (Türkiye), 06510
- Recrutement
- Lokman Hekim University, Ankara, Ankara
-
Contact:
- Demet Öztürk, Phd
- Numéro de téléphone: 05068394288
- E-mail: demett.ozturkk@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Being an undergraduate student in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University
- Being in the final examination period during the data collection process
- Having sufficient reading and comprehension skills to complete the questionnaires independently
- Voluntarily agreeing to participate in the study after reading and signing the informed consent form
Exclusion Criteria:
- Having inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, celiac disease, colorectal cancer, or a history of major gastrointestinal surgery
- Having diagnosed irritable bowel syndrome or another organic gastrointestinal disease
- Regular use of laxatives or medications that directly affect bowel movements, such as opioids
- Having neurological diseases that may affect bowel function, such as multiple sclerosis, Parkinson's disease, or spinal cord injury
- Having had an acute gastrointestinal infection within the last month
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
University Students
Undergraduate students aged 18 years and older who are studying in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires assessing test anxiety, bowel habits, stool form, constipation status, and constipation severity during a single face-to-face assessment session.
|
Les participants ont rempli des formulaires d'évaluation et des journaux.
Aucune intervention n'a été administrée.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Constipation Status Assessed by the Rome IV Criteria
Délai: Baseline (Day 1)
|
Constipation status will be assessed using the Rome IV criteria.
This outcome will be reported as a binary classification: presence or absence of constipation.
Participants will be classified as having constipation or not having constipation according to constipation-related symptoms, including reduced stool frequency, straining, hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, and need for manual maneuvers.
The Rome IV criteria will not be reported as a scale score.
|
Baseline (Day 1)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Constipation Severity Assessed by the Constipation Severity Instrument
Délai: Baseline (Day 1)
|
Constipation severity will be assessed using the Constipation Severity Instrument.
The scale includes 16 items and evaluates constipation-related symptoms across three subdomains: obstructive defecation, colonic inertia, and pain.
The total score ranges from 0 to 73, with higher scores indicating more severe constipation symptoms.
|
Baseline (Day 1)
|
|
Stool Form Assessed by the Bristol Stool Scale
Délai: Baseline (Day 1)
|
Stool form will be assessed using the Bristol Stool Scale.
The Bristol Stool Scale is a 7-point stool form classification scale ranging from Type 1 to Type 7. Type 1 indicates separate hard lumps, and Type 7 indicates watery stool with no solid pieces.
Higher scores do not indicate a better or worse outcome; lower scores generally indicate harder stool forms, while higher scores indicate looser stool forms.
Participants will be asked to select the stool type that best represents their most common stool form during the last week.
|
Baseline (Day 1)
|
|
Test Anxiety Level Assessed by the Test Anxiety Inventory
Délai: Baseline (Day 1)
|
Test anxiety level will be assessed using the Test Anxiety Inventory.
The scale consists of 20 self-report items evaluating cognitive, emotional, and physiological symptoms of anxiety experienced before and during examinations.
Total scores range from 20 to 80, with higher scores indicating higher test anxiety.
|
Baseline (Day 1)
|
|
Bowel Habits and Bowel-Related Symptoms
Délai: Baseline (Day 1)
|
Bowel habits and bowel-related symptoms will be assessed using a researcher-developed evaluation form.
The form includes questions about stool frequency, postponement of defecation, perceived bowel health, preferred toilet type, and symptoms such as abdominal pain, bloating, gas, diarrhea, nausea, vomiting, indigestion, and constipation during the last week.
|
Baseline (Day 1)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2026032
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .